Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Cytotoxic T-lymphocyte protein 4 inhibitor Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Carcinoma, Hepatocellular 2 D006528 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Thymoma 2 D013945 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Triple Negative Breast Neoplasms 1 D064726 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4650483